Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

NCT01110044 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.

Conditions

Interventions

Sponsor

GlaxoSmithKline